rs1553687887
Positions:
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 3P and 1B. PM2PP2BP6
The NM_003042.4(SLC6A1):c.152T>A(p.Phe51Tyr) variant causes a missense change. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: not found (cov: 32)
Consequence
SLC6A1
NM_003042.4 missense
NM_003042.4 missense
Scores
1
8
10
Clinical Significance
Conservation
PhyloP100: 6.09
Genes affected
SLC6A1 (HGNC:11042): (solute carrier family 6 member 1) The protein encoded by this gene is a gamma-aminobutyric acid (GABA) transporter that localizes to the plasma membrane. The encoded protein removes GABA from the synaptic cleft, restoring it to presynaptic terminals. [provided by RefSeq, Jan 2017]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 2 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
PP2
Missense variant in gene, where missense usually causes diseases (based on misZ statistic), SLC6A1. . Gene score misZ 4.1766 (greater than the threshold 3.09). Trascript score misZ 4.9229 (greater than threshold 3.09). GenCC has associacion of gene with myoclonic-atonic epilepsy, myoclonic-astatic epilepsy.
BP6
Variant 3-11017363-T-A is Benign according to our data. Variant chr3-11017363-T-A is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 475474.We mark this variant Likely_benign, oryginal submissions are: {Uncertain_significance=1, Benign=1}.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SLC6A1 | NM_003042.4 | c.152T>A | p.Phe51Tyr | missense_variant | 3/16 | ENST00000287766.10 | NP_003033.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SLC6A1 | ENST00000287766.10 | c.152T>A | p.Phe51Tyr | missense_variant | 3/16 | 1 | NM_003042.4 | ENSP00000287766.4 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 genomes
Cov.:
32
GnomAD4 exome Cov.: 31
GnomAD4 exome
Cov.:
31
GnomAD4 genome Cov.: 32
GnomAD4 genome
Cov.:
32
Bravo
AF:
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:1
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
Myoclonic-astatic epilepsy Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Oct 31, 2018 | - - |
Myoclonic-atonic epilepsy Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jul 07, 2023 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
BayesDel_addAF
Uncertain
D
BayesDel_noAF
Uncertain
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Benign
T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;.;T;T;.;.;.
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;D;T;D;T
M_CAP
Benign
T
MetaRNN
Uncertain
D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D
MetaSVM
Benign
T
MutationAssessor
Benign
L;L;L;L;L;L;L;L;L;L;L;L;L;L;L;L;L;.;L;L;.;.;.
PrimateAI
Pathogenic
D
PROVEAN
Benign
.;N;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.
REVEL
Uncertain
Sift
Benign
.;D;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.
Sift4G
Benign
.;T;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.
Polyphen
B;B;B;B;B;B;B;B;B;B;B;B;B;B;B;B;B;.;B;B;.;.;.
Vest4
0.60
MutPred
Gain of ubiquitination at K48 (P = 0.0872);Gain of ubiquitination at K48 (P = 0.0872);Gain of ubiquitination at K48 (P = 0.0872);Gain of ubiquitination at K48 (P = 0.0872);Gain of ubiquitination at K48 (P = 0.0872);Gain of ubiquitination at K48 (P = 0.0872);Gain of ubiquitination at K48 (P = 0.0872);Gain of ubiquitination at K48 (P = 0.0872);Gain of ubiquitination at K48 (P = 0.0872);Gain of ubiquitination at K48 (P = 0.0872);Gain of ubiquitination at K48 (P = 0.0872);Gain of ubiquitination at K48 (P = 0.0872);Gain of ubiquitination at K48 (P = 0.0872);Gain of ubiquitination at K48 (P = 0.0872);Gain of ubiquitination at K48 (P = 0.0872);Gain of ubiquitination at K48 (P = 0.0872);Gain of ubiquitination at K48 (P = 0.0872);Gain of ubiquitination at K48 (P = 0.0872);Gain of ubiquitination at K48 (P = 0.0872);Gain of ubiquitination at K48 (P = 0.0872);Gain of ubiquitination at K48 (P = 0.0872);Gain of ubiquitination at K48 (P = 0.0872);Gain of ubiquitination at K48 (P = 0.0872);
MVP
0.98
MPC
1.2
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at